1:05 - 1:25 pmSaturday, September 26
Plenary Hall
Using disparate data to personalize digital health behavior change interventions
Plenary Hall
Using disparate data to personalize digital health behavior change interventions
MEMOTEXT Corporation
Despite advances in the use of mobile and digital health technology, there is still an enormous gap between delivery, adoption and long-term use of digital health interventions. Much of the work of the... Read more

Description

Despite advances in the use of mobile and digital health technology, there is still an enormous gap between delivery, adoption and long-term use of digital health interventions. Much of the work of the last few years has focused on short-term outcomes (<= 3-6 months ) and the initial uptake of digital health technology. 

MEMOTEXT has shown that by collecting disparate sources of data from patient self-report, claims-data, wearables and EMRs, our personalized and evidence-based digital health interventions can achieve long term adoption and significant changes in patient behaviour.

Validated in a number of clinical and commercial settings MEMOTEXT has spent the last few years creating a development methodology, building personalization algorithms and improving adherence to medications, blood-glucose testing, and overall treatment adherence. 

With a case study approach, we can demonstrate that the use of multi-dimensional data from patient self-report (e.g. mood, quality of life, perceptual barriers to adherence) combined with objective data sources (e.g prescription claims  data, real-time blood glucose levels) can extend digital engagement over the long-term. MEMOTEXT has live pilot implementations in place with stakeholders including Pharmacy Benefit Management (PerformRx), Health plans (GreenShield Canada), pharmaceutical manufacturers (Genentech) and providers (Johns Hopkins University) to demonstrate the efficacy of employing a two-tiered data driven digital health intervention. 

Since 2008, Amos has led the design and deployment of dozens of digital patient adherence and behavior change programs globally while advocating for evidence-based approaches to technology-based behavior change.
 
Prior to founding MEMOTEXT, Amos held multiple technology and finance related positions within the Bell Canada Holdings family of companies as well as a background in social and private real estate development.Amos holds a M.Sc. in Analysis, Design and Management of Information Systems from The London School of Economics in London England, graduating with distinction was highlighted by his work within the launch of the world's first independent exchange for international wholesale telecom capacity.
 
Amos speaks regularly at events such as : mHealth, Stanford Mobile Health, Health Datapalooza, Genentech FutureMed2.0 and has guest lectured at the Univ. of Toronto
Contact Us

We're not around right now. But you can send us an email and we'll get back to you, asap.

Not readable? Change text. captcha txt

Start typing and press Enter to search